Keith Bradley's most recent trade in Integra Lifesciences Holdings Corp was a trade of 19,592 Common Stock done . Disclosure was reported to the exchange on May 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 19,592 | 89,136 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. | 09 May 2025 | 392 | 69,544 (0%) | 0% | 12.3 | 4,802 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,696 | 70,175 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.99 per share. | 09 May 2024 | 202 | 69,973 (0%) | 0% | 26.0 | 5,250 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.00 per share. | 09 May 2024 | 37 | 69,936 (0%) | 0% | 26 | 962 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 4,486 | 60,848 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 816 | 61,664 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.05 per share. | 12 May 2023 | 156 | 61,479 (0%) | 0% | 49.1 | 7,652 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.03 per share. | 12 May 2023 | 29 | 61,635 (0%) | 0% | 49.0 | 1,422 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,456 | 55,860 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 633 | 56,493 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 13 May 2022 | 131 | 56,362 (0%) | 0% | 59.3 | 7,771 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 2,896 | 52,404 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.65 per share. | 13 May 2021 | 48 | 49,508 (0%) | 0% | 70.6 | 3,391 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.67 per share. | 13 May 2021 | 9 | 49,556 (0%) | 0% | 70.7 | 636 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.15 per share. | 13 Feb 2021 | 48 | 49,565 (0%) | 0% | 69.1 | 3,319 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.11 per share. | 13 Feb 2021 | 9 | 49,613 (0%) | 0% | 69.1 | 622 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.12 per share. | 13 Nov 2020 | 48 | 49,622 (0%) | 0% | 56.1 | 2,694 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.11 per share. | 13 Nov 2020 | 9 | 49,670 (0%) | 0% | 56.1 | 505 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.73 per share. | 13 Aug 2020 | 48 | 49,679 (0%) | 0% | 51.7 | 2,483 | Common Stock |
Integra Lifesciences Holdi... | Keith Bradley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.67 per share. | 13 Aug 2020 | 9 | 49,727 (0%) | 0% | 51.7 | 465 | Common Stock |